{"nctId":"NCT01694433","briefTitle":"\"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy\"","startDateStruct":{"date":"2013-02"},"conditions":["Acne Vulgaris"],"count":66,"armGroups":[{"label":"Calcipotriene Cream","type":"EXPERIMENTAL","interventionNames":["Drug: Calcipotriene"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Calcipotriene","otherNames":["Dovonex","Vitamin D cream"]},{"name":"Placebo","otherNames":["Placebo cream manufactured to mimic calcipotriene"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Age 18 years or older, of either gender and any racial/ethnic group\n2. Subjects must have clinically evident mild to moderate acne vulgaris of the facial area, IGA scale, grade 2-4\n3. Subjects must understand and sign the informed consent prior to participation\n4. Subjects must be in generally good health\n5. Subjects must be able and willing to comply with the requirements of the protocol\n\nExclusion Criteria:\n\n1. Oral retinoid use within twelve months of entry into the study\n2. Systemic acne therapies (oral antibiotics) within 30 days of entry into the study\n3. Topical acne therapies (retinoids, antibiotics) within 14 days of entry into the study\n4. Non-compliant patients\n5. Pregnant or nursing women\n6. Subjects with a significant medical history or concurrent condition that the investigator(s) feel is not safe for study participation\n7. Subjects with hypercalcemia (hyperparathyroidism, kidney disease)\n8. Subjects who cannot avoid excessive exposure to either natural or artificial sunlight.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Lesion Counts (Total, Inflammatory and Non-inflammatory)","description":"Lesion counts will be assessed by one of the investigator physicians or nurse practitioner.","paramType":"MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.4","spread":null},{"groupId":"OG001","value":"13.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.8","spread":null},{"groupId":"OG001","value":"9.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.1","spread":null},{"groupId":"OG001","value":"10.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.5","spread":null},{"groupId":"OG001","value":"7.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.9","spread":null},{"groupId":"OG001","value":"33.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35.5","spread":null},{"groupId":"OG001","value":"34.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22.1","spread":null},{"groupId":"OG001","value":"24.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.6","spread":null},{"groupId":"OG001","value":"20.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"51.0","spread":null},{"groupId":"OG001","value":"46.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"51.4","spread":null},{"groupId":"OG001","value":"44.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34.2","spread":null},{"groupId":"OG001","value":"34.55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.1","spread":null},{"groupId":"OG001","value":"27.24","spread":null}]}]}]},{"type":"SECONDARY","title":"Acne Severity as Assessed With the Investigator's Global Assessment (IGA)","description":"Investigator's Global Assessment (IGA) is a 5-point scale of acne severity, ranging from 0 (Clear) to 4 (Severe)","paramType":"MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.77","spread":null},{"groupId":"OG001","value":"2.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.83","spread":null},{"groupId":"OG001","value":"2.59","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.21","spread":null},{"groupId":"OG001","value":"2.48","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.23","spread":null},{"groupId":"OG001","value":"2.31","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":33},"commonTop":["Facial dryness","Common cold/allergy","Redness","Facial irritation","Acne"]}}}